V

ViroGates A/S
CSE:VIRO

Watchlist Manager
ViroGates A/S
CSE:VIRO
Watchlist
Price: 14.2 DKK -3.73% Market Closed
Market Cap: 109.9m DKK
Section:
 

Relative Value

The Relative Value of one VIRO stock under the Base Case scenario is 2 DKK. Compared to the current market price of 14.2 DKK, ViroGates A/S is Overvalued by 86%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIRO Relative Value
Base Case
2 DKK
Overvaluation 86%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

21.8
P/S
P/S
Price to Sales
21.8
vs History
5
vs Industry
8
Median 3Y
14.2
Median 5Y
14.2
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-4.9
Industry
22.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-7
Median 5Y
-7
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7
Median 5Y
-7
Industry
21.5
More Details
38.7
P/B
P/B
Price to Book Value
38.7
vs History
5
vs Industry
7
Median 3Y
7.9
Median 5Y
7.9
Industry
2.2
More Details
20.7
EV/S
EV/S
Enterprise Value to Sales
20.7
vs History
5
vs Industry
8
Median 3Y
12.8
Median 5Y
12.8
Industry
2.5
More Details
43.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
43.7
vs History
5
vs Industry
7
Median 3Y
28.6
Median 5Y
28.6
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-4.3
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-4.3
Industry
17.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-6.2
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-6.2
Industry
18.8
More Details
23.5
EV/IC
EV/IC
Enterprise Value to IC
23.5
vs History
5
vs Industry
8
Median 3Y
13.2
Median 5Y
13.2
Industry
1.8
More Details

Multiples Across Competitors

VIRO Competitors Multiples
ViroGates A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
ViroGates A/S
CSE:VIRO
109.8m DKK 21.8 -8.9 -8.3 -8.3
US
Abbott Laboratories
NYSE:ABT
218.2B USD 5 15.6 19.9 27.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
194.4B USD 20.2 70.8 54.1 66
US
Boston Scientific Corp
NYSE:BSX
137.2B USD 7.1 49.2 28.8 39.2
US
Stryker Corp
NYSE:SYK
135.4B USD 5.6 46 22.5 27.2
IE
Medtronic PLC
NYSE:MDT
128B USD 3.7 26.9 15.1 21.8
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR 2.1 23.1 13.1 18.4
US
Becton Dickinson and Co
NYSE:BDX
57.3B USD 2.6 34.2 12.6 21.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.3B USD 13.5 54.8 39.4 43.6
US
Edwards Lifesciences Corp
NYSE:EW
48.2B USD 8.2 35.3 25.2 27.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.2B USD 1.9 17.3 12.9 15.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
V
ViroGates A/S
CSE:VIRO
Average EV/EBITDA: 24.3
Negative Multiple: -8.3 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.9
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
54.1
26%
2.1
US
Boston Scientific Corp
NYSE:BSX
28.8
22%
1.3
US
Stryker Corp
NYSE:SYK
22.5
13%
1.7
IE
Medtronic PLC
NYSE:MDT
15.1
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.1
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.6
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.4
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.2
13%
1.9
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
12.9
10%
1.3

See Also

Summary
VIRO intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIRO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIRO stock valuation using valuation multiples.
Wall Street Estimates
VIRO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIRO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.